| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15c9046e329a8ec137cea6d6d013b578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bbcf6fd609debdac635c00ec9cb8a16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_864025831144ed14022b71be091171b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 |
| filingDate |
2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b95254ba46f110235cfb17065f3baf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4935219cb889520833f7d917339a8d59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d0445f329cb9e309e550df8bd2d169 |
| publicationDate |
2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1753439-A2 |
| titleOfInvention |
Use of umbilical cord blood stem cells to treat ischemic event |
| abstract |
The invention relates to isolated mammalian umbilical cord stem cells that are Oct-4+ and that are surface antigen negative for CD34, compositions containing these cells their use for treating damaged neuronal tissue, particularly where the damage is due to ischemia. |
| priorityDate |
2004-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |